Feb 13 (Reuters) - Davita Inc:
* Q4 ADJUSTED EARNINGS PER SHARE $0.92 FROM CONTINUING OPERATIONS
* DAVITA- IN QUARTER, RECOGNIZED A NON-CASH OTHER-THAN-TEMPORARY IMPAIRMENT CHARGE OF $280 MILLION ON INVESTMENT IN ASIA PACIFIC JOINT VENTURE
* ‍AS A RESULT OF RECENT U.S. TAX REFORM LEGISLATION, RECORDED A REDUCTION IN TAX EXPENSE OF $252 MILLION FOR QUARTER AND YEAR ENDED DECEMBER 31
* ‍STILL EXPECT OUR KIDNEY CARE CONSOLIDATED OPERATING INCOME FOR 2018 TO BE IN RANGE OF $1.5 BILLION TO $1.6 BILLION​
* ‍EXPECT OPERATING CASH FLOW FROM CONTINUING OPERATIONS FOR 2018 TO BE IN RANGE OF $1.4 BILLION TO $1.6 BILLION​
* TOTAL U.S. DIALYSIS TREATMENTS FOR Q4 WERE 7.2 MILLION OR 92,287 TREATMENTS PER DAY, REPRESENTING A PER DAY INCREASE OF 5.8% OVER Q4 OF 2016
* Q4 EARNINGS PER SHARE VIEW $0.94 — THOMSON REUTERS I/B/E/S
* QTRLY TOTAL NET REVENUES $2.78 BILLION VERSUS $2.7 BILLION LAST YEAR
* Q4 REVENUE VIEW $3.89 BILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: